NM_015122.3:c.97C>G

Variant summary

Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BS1_Supporting

The NM_015122.3(FCHO1):​c.97C>G​(p.Leu33Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,466 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L33P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000055 ( 0 hom. )

Consequence

FCHO1
NM_015122.3 missense

Scores

2
10
7

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:2

Conservation

PhyloP100: 2.26

Publications

0 publications found
Variant links:
Genes affected
FCHO1 (HGNC:29002): (FCH and mu domain containing endocytic adaptor 1) Enables AP-2 adaptor complex binding activity. Involved in clathrin coat assembly and clathrin-dependent endocytosis. Located in cytosol; nucleoplasm; and plasma membrane. Is active in clathrin-coated pit. Implicated in primary immunodeficiency disease. [provided by Alliance of Genome Resources, Apr 2022]
FCHO1 Gene-Disease associations (from GenCC):
  • immunodeficiency 76
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 1 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BS1
Variant frequency is greater than expected in population amr. GnomAdExome4 allele frequency = 0.00000547 (8/1461282) while in subpopulation AMR AF = 0.000179 (8/44724). AF 95% confidence interval is 0.0000886. There are 0 homozygotes in GnomAdExome4. There are 2 alleles in the male GnomAdExome4 subpopulation. Median coverage is 30. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FCHO1NM_015122.3 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENST00000596536.6 NP_055937.1 O14526-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FCHO1ENST00000596536.6 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 5 NM_015122.3 ENSP00000470731.1 O14526-1
FCHO1ENST00000699212.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 30 ENSP00000514208.1 A0A8V8TPN1
FCHO1ENST00000594202.6 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 5 ENSP00000473001.1 A0A0C3SFZ9
FCHO1ENST00000596309.6 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 4 ENSP00000470511.2 O14526-1M0QZF0
FCHO1ENST00000596951.6 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 5 ENSP00000472417.1 O14526-1
FCHO1ENST00000600209.6 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 5 ENSP00000469075.2 O14526-1M0QXD1
FCHO1ENST00000600676.5 linkc.97C>G p.Leu33Val missense_variant Exon 4 of 28 2 ENSP00000470493.1 O14526-1
FCHO1ENST00000699176.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514179.1 O14526-1
FCHO1ENST00000699177.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514180.1 O14526-1
FCHO1ENST00000699207.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514204.1 O14526-1
FCHO1ENST00000699209.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514206.1 O14526-1
FCHO1ENST00000699215.1 linkc.97C>G p.Leu33Val missense_variant Exon 4 of 28 ENSP00000514211.1 O14526-1
FCHO1ENST00000699202.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514200.1 A0A8V8TMX9
FCHO1ENST00000699214.1 linkc.97C>G p.Leu33Val missense_variant Exon 4 of 28 ENSP00000514210.1 A0A8V8TMX9
FCHO1ENST00000699208.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 28 ENSP00000514205.1 A0A8V8TPA0
FCHO1ENST00000699198.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 29 ENSP00000514196.1 M0QYA9
FCHO1ENST00000699199.1 linkc.97C>G p.Leu33Val missense_variant Exon 4 of 28 ENSP00000514197.1 M0QYA9
FCHO1ENST00000699213.1 linkc.97C>G p.Leu33Val missense_variant Exon 4 of 28 ENSP00000514209.1 M0QYA9
FCHO1ENST00000699197.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 28 ENSP00000514195.1 A0A8V8TNC3
FCHO1ENST00000699200.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 28 ENSP00000514198.1 A0A8V8TNC3
FCHO1ENST00000699196.1 linkc.97C>G p.Leu33Val missense_variant Exon 5 of 27 ENSP00000514194.1 A0A8V8TP91
FCHO1ENST00000699201.1 linkn.97C>G non_coding_transcript_exon_variant Exon 5 of 28 ENSP00000514199.1 A0A8V8TP96
FCHO1ENST00000699205.1 linkn.97C>G non_coding_transcript_exon_variant Exon 5 of 27 ENSP00000514202.1 A0A8V8TMV7
FCHO1ENST00000699206.1 linkn.97C>G non_coding_transcript_exon_variant Exon 5 of 29 ENSP00000514203.1 A0A8V8TMV7
FCHO1ENST00000699210.1 linkn.97C>G non_coding_transcript_exon_variant Exon 5 of 28 ENSP00000514207.1 A0A8V8TND1
FCHO1ENST00000699203.1 linkc.-54C>G 5_prime_UTR_variant Exon 3 of 22 ENSP00000514201.1 A0A8V8TPM7

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000358
AC:
9
AN:
251398
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000547
AC:
8
AN:
1461282
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
2
AN XY:
726994
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33470
American (AMR)
AF:
0.000179
AC:
8
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86236
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53408
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5730
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111506
Other (OTH)
AF:
0.00
AC:
0
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152184
Hom.:
0
Cov.:
31
AF XY:
0.0000135
AC XY:
1
AN XY:
74342
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41454
American (AMR)
AF:
0.0000655
AC:
1
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68034
Other (OTH)
AF:
0.00
AC:
0
AN:
2090
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113
ExAC
AF:
0.0000247
AC:
3

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 20, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.97C>G (p.L33V) alteration is located in exon 5 (coding exon 2) of the FCHO1 gene. This alteration results from a C to G substitution at nucleotide position 97, causing the leucine (L) at amino acid position 33 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

not provided Uncertain:1
Sep 21, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with FCHO1-related conditions. This variant is present in population databases (rs771754784, gnomAD 0.02%). This sequence change replaces leucine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 33 of the FCHO1 protein (p.Leu33Val). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.24
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.19
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.043
T;T;T;T;T;.;T;T;T;T;.;.;.;T;T;.;T;T;.
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.29
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Uncertain
0.93
D;D;.;D;D;D;D;.;D;D;D;D;D;D;D;D;.;D;D
M_CAP
Uncertain
0.10
D
MetaRNN
Uncertain
0.58
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM
Benign
-0.56
T
MutationAssessor
Uncertain
2.8
.;M;M;.;.;.;.;M;.;.;.;.;.;.;.;.;M;.;.
PhyloP100
2.3
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-2.4
.;N;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
REVEL
Uncertain
0.33
Sift
Pathogenic
0.0
.;D;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.;.
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D;D
Polyphen
1.0
.;D;D;.;.;.;.;D;.;.;.;.;.;.;.;.;D;.;.
Vest4
0.77
MutPred
0.68
Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);Loss of catalytic residue at L33 (P = 0.0554);.;
MVP
0.39
MPC
1.6
ClinPred
0.88
D
GERP RS
2.1
PromoterAI
-0.0020
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.53
gMVP
0.90
Mutation Taster
=50/50

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs771754784; hg19: chr19-17873640; API